DAVID GARDELIUS: Open Payments
NPI 1316615578 · KLAMATH FALLS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 10 payments from 5 companies in 2025. Trend: 2023 $45 · 2024 $1,181 · 2025 $285
Food & beverage: $189Education: $96
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $96 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| GENZYME CORPORATION | 1 | $22 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, Sunosi, FASENRA, AIRSUPRA, BREZTRI.
Industry payments across OR — which companies pay providers there.
